Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Forebyggelse af Rhesusimmunisering. II. Imödegåelse af risiko i sidste halvdel af graviditeten og ved födslen
Engelsk titel: Prevention of Rh immunisation. II. Management of the risk during the second half of pregnancy and postpartum Läs online Författare: Falck Larsen J ; Bock JE ; Jörgensen JR Språk: Dan Antal referenser: 35 Dokumenttyp: Översikt UI-nummer: 04081010

Tidskrift

Ugeskrift for Laeger 2004;166(36)3078-83 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Based on evidence from the literature, the following guidelines are recommended: 100 µg of IgG anti-D should be given within 72 hours of delivery to non-sensitised rhesus-negative women. Additional IgG anti-D should be given if a feto-maternal haemorrhage greater than 4 ml foetal erythrocytes is detected. Antenatal prophylaxis is recommended for all rhesus-negative women, with two injections of 100 µg of IgG anti-D at 28 and 34 weeks. Amniocentesis and chordocentesis, as well as external version of the fetus, should be performed in rhesus-negative women only if the indication is very strong. In these cases 100 µg of IgG anti-D should be given. In the case of severe abdominal injury in pregnancy, anti-D should be considered.